Orthofix Medica Announces The 510K Clearance And Full Commercial Launch Of OsteoCove, An Advanced Bioactive Synthetic Graft
Portfolio Pulse from Benzinga Newsdesk
Orthofix Medical has announced the 510K clearance and full commercial launch of OsteoCove, an advanced bioactive synthetic graft. This development could potentially boost the company's revenues and market share in the medical devices sector.

October 12, 2023 | 11:30 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Orthofix Medical's new product, OsteoCove, has received 510K clearance and is now fully commercially available. This could potentially increase the company's revenues and market share.
The 510K clearance and full commercial launch of OsteoCove represents a significant milestone for Orthofix Medical. This could potentially increase the company's revenues as it allows them to sell the product in the market. Additionally, the advanced nature of the product could help the company gain a larger market share in the medical devices sector.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100